Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Operates in Healthcare Services — Specialized medicine - private practice. Per the activity note to the FY2024 annual report, the company provides licensed medical services for tuberculosis and infectious diseases treatment. Majority owned with public health profile; registered on 12 April 2016.
Group parent — controls 1 company · ownership
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3,582 | 3,887 | 6,262 | 12,420 | 6,017 | 4,300 | 3,246 | -1.6% |
| Total COGS | 589 | 884 | 1,794 | 3,360 | 5,130 | 3,961 | 2,896 | +30.4% |
| Gross Profit | 2,994 | 3,003 | 4,468 | 9,060 | 887 | 338 | 350 | -30.1% |
| Gross Margin | 83.6% | 77.3% | 71.4% | 72.9% | 14.7% | 7.9% | 10.8% | |
| 2,400 | 2,620 | 2,797 | 4,151 | 884 | 842 | 664 | -19.3% | |
| EBITDA | 593 | 383 | 1,672 | 4,909 | 3 | 504 | 315 | nmf |
| EBITDA Margin | 16.6% | 9.8% | 26.7% | 39.5% | 0.0% | 11.7% | 9.7% | |
| Total D&A | 518 | 500 | 484 | 476 | 435 | 448 | 398 | -4.3% |
| EBIT / Operating Income | 75 | 117 | 1,188 | 4,433 | 432 | 952 | 713 | nmf |
| Total Interest Income | 0 | 0 | 19 | 0 | 0 | 0 | 0 | |
| Total Interest Expense | 653 | 953 | 629 | 815 | 368 | 288 | 235 | -15.7% |
| 34 | 121 | 390 | 840 | 426 | 532 | 179 | +32.0% | |
| Profit Before Tax | 612 | 949 | 968 | 4,458 | 375 | 708 | 1,127 | +10.7% |
| Total Income Tax | 3 | 0 | 0 | 0 | 0 | 35 | 0 | +63.0% |
| Net Profit / (Loss) | 615 | 949 | 968 | 4,458 | 375 | 743 | 1,127 | +10.6% |
| Net Margin | 17.2% | 24.4% | 15.5% | 35.9% | 6.2% | 17.3% | 34.7% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →